Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Baheal Medical Inc. is a leading Chinese healthcare enterprise specializing in pharmaceutical brand commercialization and the development of innovative medical technologies. The company operates a comprehensive platform that provides marketing, distribution, and digital solutions for global pharmaceutical and medical device brands entering the Chinese market. Beyond commercialization, Baheal is actively expanding into independent R&D through its group structure, focusing on innovative drugs, high-end medical devices, and AI-driven diagnostic tools. Listed on the Shenzhen Stock Exchange, the company serves as a critical bridge between global life science innovation and the Chinese healthcare ecosystem. It leverages a vast network of hospitals and pharmacies to improve patient access to advanced treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Baheal Medical.